Chinook Therapeutics

$0.00 (0.00%) As of 11:05 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KDNY and other ETFs, options, and stocks.

About KDNY

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.

CEO
Eric L. Dobmeier
Employees
138
Headquarters
Seattle, Washington
Founded
2000

KDNY Key Statistics

Market cap
757.54M
Price-Earnings ratio
—
Dividend yield
—
Average volume
403.71K
High today
$14.15
Low today
$13.67
Open price
$14.15
Volume
428.15K
52 Week high
$19.85
52 Week low
$10.48

KDNY Earnings

-$1.24
-$0.78
-$0.32
$0.14
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.54 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure